Siena, Italy

Claudia Mugnaini

This inventor holds 1 USPTO granted patent. Top assignee: Universitá Degli Studi Di Siena. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claudia Mugnaini. Retrieved from https://idiyas.com/inventor/claudia-mugnaini

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Claudia Mugnaini: Innovator in Antibacterial Compounds

Introduction

Claudia Mugnaini is a prominent inventor based in Siena, Italy. She has made significant contributions to the field of antibacterial agents through her innovative research and development. Her work focuses on creating compounds that can effectively combat bacterial infections.

Latest Patents

Claudia Mugnaini holds a patent for antibacterial compounds. The present invention relates to compounds of formula (I), their salts, and derivatives. Additionally, the invention includes compositions that comprise at least one compound of formula (I) or its pharmaceutically acceptable salts and derivatives, along with excipients and, optionally, a further active compound. The compounds and compositions are intended for use as antibacterial agents.

Career Highlights

Mugnaini is affiliated with the Università Degli Studi di Siena, where she conducts her research and development activities. Her academic background and expertise have positioned her as a key figure in the study of antibacterial compounds.

Collaborations

Claudia has collaborated with notable colleagues, including Federico Corelli and Antonella Brizzi. These partnerships have enhanced her research efforts and contributed to the advancement of her innovative work.

Conclusion

Claudia Mugnaini's contributions to the field of antibacterial compounds highlight her role as an influential inventor. Her dedication to developing effective antibacterial agents is paving the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…